Results 21 to 30 of about 47,941 (305)

Intracervical Foley Catheter Plus Intravaginal Misoprostol vs Intravaginal Misoprostol Alone for Cervical Ripening: A Meta-Analysis

open access: yesInternational Journal of Environmental Research and Public Health, 2020
Currently, there is no meta-analysis comparing intravaginal misoprostol plus intracervical Foley catheter versus intravaginal misoprostol alone for term pregnancy without identifying risk factors.
Howard Hao Lee   +8 more
semanticscholar   +1 more source

Oral misoprostol, low dose vaginal misoprostol, and vaginal dinoprostone for labor induction: Randomized controlled trial

open access: yesPLoS ONE, 2020
Objective To compare effectiveness and safety of oral misoprostol (50 μg every four hours as needed), low dose vaginal misoprostol (25 to 50 μg every six hours as needed), and our established dinoprostone vaginal gel (one to two mg every six hours as ...
D. Young   +8 more
semanticscholar   +1 more source

Quality, availability and storage conditions of oxytocin and misoprostol in Malawi

open access: yesBMC Pregnancy and Childbirth, 2020
Background Postpartum haemorrhage (PPH) is the leading cause of maternal mortality in low- and middle-income countries (LMICs). Oxytocin and misoprostol are used for the prevention and treatment of PPH. However, both medicines are chemically unstable and
Nhomsai Hagen, Felix Khuluza, L. Heide
semanticscholar   +1 more source

Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention. [PDF]

open access: yes, 2014
BackgroundBangladesh is one of the few countries that may actually achieve the fifth Millennium Development Goal (MDG) in time, despite skilled birth attendance remaining low.
Bell, Suzanne   +2 more
core   +1 more source

The safety of misoprostol [PDF]

open access: yesInternational Journal of Gynecology & Obstetrics, 2006
TITLE: The Safety of Misoprostol AUTHOR: Anke Hemmerling, MD, MPH Bixby Fellow of Population and International Health University of California, Berkeley School of Public Health 513 Warren Hall Berkeley, CA 94720-6390 Email: anke@berkeley.edu Misoprostol, Safety, Post Partum Hemorrhage KEYWORDS: Misoprostol is currently on the WHO Essential Drug List ...
openaire   +3 more sources

PERBANDINGAN EFEKTIVITAS MISOPROSTOL DOSIS 50 µg DAN 100 µg TERHADAP KEBERHASILAN KELAHIRAN INDUKSI DI RSU PKU MUHAMMADIYAH YOGYAKARTA

open access: yesPharmaciana, 2014
In recent years, misoprostol that is a prostaglandin E1 analogue has been used in cervix ripening at pregnancy and labor induction. However, until now misoprostol dosage and administration route for induction are various.
Haafizah Dania   +2 more
doaj   +1 more source

Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats.

open access: yesPLoS ONE, 2014
Nonsteroidal anti-inflammatory drugs (NSAIDs) can produce adverse effects by inhibiting prostaglandin (PG) synthesis. A PGE1 analogue, misoprostol, is often utilized to alleviate NSAID-related gastrointestinal side effects. This study examined the effect
Dustin L Cooper   +11 more
doaj   +1 more source

Hyperpyrexia After Rectal Misoprostol Administration-A Rare Side Effect of Misoprostol: Case Report

open access: yesNovelty in Biomedicine, 2022
Background: Misoprostol is a safe drug that is one of the prostaglandins analogs. It has uterotonic solid potential and is good for postpartum hemorrhage (PPH).
Masoumeh Mirzamoradi, Yekta Parsa
doaj   +1 more source

Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. [PDF]

open access: yes, 2005
OBJECTIVE: To assess the effectiveness of 600 microg oral misoprostol on postpartum haemorrhage (PPH) and postpartum anaemia in a low income country home birth situation. DESIGN: Double blind randomised controlled trial.
Blum, Jennifer   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy